Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) had its price objective raised by stock analysts at Oppenheimer from $65.00 to $72.00 in a research note issued on Wednesday,Benzinga reports.
Donald Trump used the stock market's performance as a daily gauge of his administration's success during his first term. The S&P 500's strong breadth today may be seen by him as an early vote of ...
As the U.S. stock market experiences a positive shift following recent executive orders, investors are keenly observing potential opportunities across various sectors. Penny stocks, often associated ...
As of January 2025, the U.S. stock market is experiencing a surge, with major indices like the S&P 500 and Dow Jones Industrial Average posting their best weekly gains in two months, driven by a rally ...